more-inStrand Life Sciences, a bioinformatics and diagnostics company, on Thursday, announced it had raised $13 million from private equity firms, including Singapore-based Quadria Capital. “The total funds raised from Quadria Capital and Heritas Venture Fund, which is also Singapore-based, is $13 million,” a company official said on the condition of anonymity. Strand Life Sciences acquired Triesta Sciences, a unit of Healthcare Global Enterprises (HCG), on January four for an undisclosed amount. Next phase of growth“The partnership with Quadria and HCG will help launch Strand into the next phase of growth and into an era where data analytics and molecular measurements together change diagnosis and treatment paradigms,” Dr. Ramesh Hariharan, CEO, Strand Life Sciences, said. “The demand for specialised diagnostics has been rising rapidly across the region,” said Dr. Amit Varma, managing partner and co-founder, Quadria Capital.

Source: The Hindu February 08, 2018 16:07 UTC